An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin
Response to Barnett et al.
- Balavenkatesh Kanna, MD, MPH12 and
- Heidi Abreu-Pacheco, MD1
- 1Department of Internal Medicine, Lincoln Medical & Mental Health Center, Bronx, New York
- 2Weill Medical College of Cornell University, New York, New York
- Address correspondence to Balavenkatesh Kanna, MD, MPH, Department of Medicine, Suite 8-22, 8th Floor, 234 E. 149th St., Bronx, NY 10451. E-mail: balavenkatesh.kanna{at}nychhc.org
In response to the interesting article by Barnett et al. (1), we would like to offer the following comments. Diabetes control has been shown to improve with diet and exercise regimens (2,3). The degree …
